<DOC>
	<DOCNO>NCT01293331</DOCNO>
	<brief_summary>The purpose study detect acute febrile episodes dengue infection five Latin American country assess dengue seroprevalence . Primary objective : - To identify acute febrile episode among cohort order detect presence dengue infection . - To describe dengue seroprevalence among cohort baseline end study .</brief_summary>
	<brief_title>Study Febrile Illness Dengue-Endemic Areas Latin America</brief_title>
	<detailed_description>All participant make two visit study site , enrollment visit termination visit . Additional visit make febrile episode occur : acute visit convalescent visit . Participants parents/guardians contact weekly monitor occurrence febrile episodes ensure appropriate assessment care . No vaccine provide administer study</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Dengue</mesh_term>
	<criteria>Inclusion Criteria : Aged 9 16 year day inclusion resident site zone Participant good health , base medical history physical examination Assent form sign date participant ( required local regulation ) , informed consent form sign dated parent ( ) another legally acceptable representative ( participant and/or independent witness require local regulation ) Participant able attend schedule visit comply study procedure Exclusion Criteria : Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede enrollment Planned participation another clinical trial present study period Known suspect congenital acquired immunodeficiency ; receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) Selfreported seropositivity Human Immunodeficiency Virus ( HIV ) infection Chronic illness , opinion Investigator , stage might interfere study conduct completion Current alcohol abuse drug addiction may interfere participant 's ability comply study procedure Receipt blood bloodderived product past 3 month Receipt vaccine 4 week precede day enrollment except pandemic influenza vaccination , may receive least 2 week enrollment Planned receipt vaccine 4 week follow enrollment Deprived freedom administrative court order , emergency setting , hospitalize involuntarily Identified employee Investigator study center , direct involvement propose study study direction Investigator study center , well family member ( i.e. , immediate , husband , wife child , adopt natural ) employee Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Dengue Fever Fever Seroprevalence</keyword>
</DOC>